<DOC>
	<DOCNO>NCT02764606</DOCNO>
	<brief_summary>CANPOS non-interventional study aim evaluate time initial surgery value new serum marker predict occurrence metastasis patient early-stage non-small cell lung cancer . This would represent rational develop personalized follow-up prevention strategy</brief_summary>
	<brief_title>CANPOS : Predictive Biomarkers Tumor Progression Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>patient diagnosis suspect diagnosis lung cancer , nonsmall cell lung cancer age 18 year patient na√Øve oncology treatment ( exclude surgery alone ) within past 5 year patient sign informed consent study protocol Exclusion criterion : ongoing treatment cancer history cancer within 5 year diagnosis lung cancer psychological , sociological geographical condition would allow study followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Bone</keyword>
	<keyword>Metastases</keyword>
</DOC>